Remove 2017 Remove Communication Remove Compounding
article thumbnail

The digital transformation of pharma’s physician engagement strategies

pharmaphorum

The pandemic has ushered in a number of major changes to healthcare systems, notably in the ways in which pharmaceutical companies communicate, visit and engage with physicians. The threat of disease spread and other risk factors from COVID-19 have only compounded this.

article thumbnail

Digital strategies for pharma’s physician engagement

pharmaphorum

Just as the wider healthcare system continues to acclimate to a new normal, the way pharma and physicians communicate is experiencing a technological revolution. Physician access issues coupled with message delivery disconnects only compounded the problem. Inefficient communications pre-COVID.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How to take care of your BIPOC patients

The Checkup by Singlecare

The negative outcomes for BIPOC patients are compounded by the (understandable) anxiety about and distrust for the healthcare system and its providers. It’s worth considering how you can do so, such as through building trust and open communication. Sources: How legacy of medical racism shapes U.S. health care today.

article thumbnail

Contamination Trends & Proposed Solutions

ISPE

11 Table 1: Contamination-associated recalls from 2017 to 2021. 5 , 8 Compounding pharmacies were commonly mentioned as sources of microbial cross-contamination, especially in the US. 5 , 8 Compounding pharmacies were commonly mentioned as sources of microbial cross-contamination, especially in the US. 4 (2017): 389–394.

article thumbnail

Three strategies for managing loss of exclusivity successfully

pharmaphorum

Eli Lilly’s Humalog compound and formulation patents expired in 2013 and 2014, respectively. In late 2017, the FDA approved Admelog, Sanofi’s biosimilar of Humalog. Since losing exclusive rights in 2017, Pfizer undertook an over-the-counter switching strategy to guard against revenue loss.

article thumbnail

Message from the Chair an Exciting Year

ISPE

Reintroducing the liaison role of International Board members with individual Chapters and Affiliates has given us direct lines of communication to the mutual benefit of the International Board and the local groups. Tim Howard, who was Chair of the International Board from 2017–2018, helped by moderating the sessions. Thank you, Tim!

article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

The review was impacted by Brexit and the COVID-19 pandemic, which compounded existing issues surrounding high drug pricing and patient access that had been brewing since 2016 and highlighted several shortcomings in the EU’s pharmaceutical system. Maarten has significant competition law experience in a variety of sectors. About the author.